candesartan has been researched along with temocapril hydrochloride in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akioka, K; Iwao, H; Kim, S; Omura, T; Shimada, K; Takeuchi, K; Teragaki, M; Yamagishi, H; Yoshikawa, J; Yoshiyama, M | 1 |
Hayashi, H; Horiguchi, M; Hosoya, T; Ishikawa, M; Kobayashi, H; Kuriyama, S; Tokudome, G; Tomonari, H | 1 |
Furuhashi, M; Higashiura, K; Moniwa, N; Murakami, H; Shimamoto, K; Tanaka, M; Ura, N; Yoshida, D | 1 |
Arai, T; Koji, Y; Kushiro, T; Motobe, K; Tomiyama, H; Yamashina, A; Yambe, M; Zaydun, G | 1 |
Daimon, M; Hasegawa, R; Himi, T; Kawata, T; Komuro, I; Sekine, T; Teramoto, K; Toyoda, T; Uchida, D; Yamamoto, K; Yoshida, K | 1 |
Ito, S; Mori, T; Nako, K; Ogawa, S; Takeuchi, K; Tsubono, Y | 1 |
4 trial(s) available for candesartan and temocapril hydrochloride
Article | Year |
---|---|
Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy.
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pilot Projects; Proteinuria; Tetrazoles; Thiazepines; Treatment Outcome | 2002 |
Insulin sensitivity and endothelial function in hypertension: a comparison of temocapril and candesartan.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cross-Over Studies; Endothelium, Vascular; Humans; Hypertension; Insulin Resistance; Nitric Oxide; Single-Blind Method; Tetrazoles; Thiazepines; Tumor Necrosis Factor-alpha | 2005 |
Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Coronary Circulation; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Single-Blind Method; Tetrazoles; Thiazepines | 2006 |
Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cost-Benefit Analysis; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Tetrazoles; Thiazepines | 2007 |
2 other study(ies) available for candesartan and temocapril hydrochloride
Article | Year |
---|---|
Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; DNA; Echocardiography, Doppler, Color; Heart Ventricles; Hemodynamics; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Signal Transduction; Sp1 Transcription Factor; Tetrazoles; Thiazepines; Time Factors; Transcription Factor AP-1 | 2001 |
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension.
Topics: Adiponectin; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Female; Glucose Clamp Technique; Humans; Hypertension; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Proteins; Renin-Angiotensin System; Tetrazoles; Thiazepines | 2003 |